Get a glimpse into our company and investor data—powered by the PitchBook Platform
Watson Pharmaceutical (14 generic products)
Buyout/LBOLATEST DEAL TYPE
Fourteen generic drug components. The fourteen products include five generic products marketed in the United States, eight abbreviated new drug applications and a generic product in late-stage development.